Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 3Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Hematopoietic and Lymphatic System Neoplasm 2Colorectal Neoplasms 2COVID-19 2Breast Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Spondylitis, Ankylosing 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Malignant Solid Neoplasm 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Hypogonadism 1Head and Neck Neoplasms 1HIV Infections 1Death 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Bilateral Breast Carcinoma 1Autoimmune Diseases 1

Interventions

testosterone 17 beta-cypionate 1pembrolizumab 1enfortumab vedotin 1Testosterone Propionate 1Standard of Care 1Practice Guidelines as Topic 1Methyltestosterone 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Practice Guidelines as Topic × 30 days × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡